The stocks listed here have all been struggling due to weak demand. They are cheap-looking buys that investors haven't been ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

Shares of Moderna closed nearly 17% lower Monday. Other vaccine stocks also fell, with Novavax and BioNTech both ending more than 7% lower. "As we head into 2025, there are a handful of uncertainties ...

The impact of this deal on the stock market has been quite bullish, especially for AI-related companies and those involved in ...

BioSolutions' strategic turnaround plan and cost-cutting efforts are paving the way for profitability in 2025. Explore more ...

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

In a report released today, Tim Anderson from Bank of America Securities maintained a Sell rating on Moderna (MRNA – Research Report), with a ...

According to a 2023 PwC report, the AI market in healthcare was valued at $11 billion and is expected to grow to $188 billion by 2030. On January 21st, Oracle Co-founder Larry Ellison said during a ...

President Donald Trump talked up a joint venture investing up to $500 billion for infrastructure tied to AI by a new ...